Screener
Immix Biopharma, Inc. IMMX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Immix Biopharma, Inc.’s reported figures.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
FAQ
- What is Immix Biopharma, Inc.'s free cash flow?
- Immix Biopharma, Inc. (IMMX) reported free cash flow of -$9.86M in Q1 2026.
- How has Immix Biopharma, Inc.'s free cash flow changed year-over-year?
- Immix Biopharma, Inc.'s free cash flow decreased by 462.5% year-over-year, from -$1.75M to -$9.86M.
- What is the long-term trend for Immix Biopharma, Inc.'s free cash flow?
- Over 2 years (2021 to 2025), Immix Biopharma, Inc.'s free cash flow has grown at a 293.8% compound annual growth rate (CAGR), from -$1.59M to -$24.66M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Immix Biopharma, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude